Free tool
Oncology stocks
We cover 2 companies grouped under the Oncology theme. The median market value in the group is $2.11B. Across the group, the median move over the past trading day is +2.63%. Price change over the past year runs from +19.5% to +320.6% across the middle 80 percent of the group, with a median of +170.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
2 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| HCM.L | HUTCHMED (China) Limited | $2.16B | Mid cap | −18.08% |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +358.21% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.